Colony stimulating factor-1 receptor (CSF-1R) inhibitors

US11274108B2 · kind B2 · utility

Assignee

• Genzyme Corporation · US

Inventors

• John Kane · Maynard, US
• Claude Barberis · Ayer, US
• Mark Czekaj · Maple Shade, US
• Paul E. Erdman · San Diego, US
• Barret Giese · Wyckoff, US
• Michael Kothe · Medway, US
• Tieu-Binh Le · Bound Brook, US
• Jinyu Liu · Acton, US
• Liang Ma · Fryeburg, US
• Markus Metz · Bellevue, US
• Vinod F. Patel · Acton, US
• Andrew Scholte · Somerville, US
• Patrick W. Shum · Holliston, US
• Linli Wei · Bound Brook, US

Key dates

• Filing date: Jul 19, 2016
• Grant date: Mar 15, 2022
• Expiry date: Jul 19, 2036

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D487/04
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Compounds of the formulas which are useful as colony stimulating factor-1 receptor inhibitors (“CSF-1R inhibitors”).